Agenda Topics- Adult Stem Cells for Cellular Therapy
- Bone Marrow vs. Adipose-derived Stem Cells
- Clinical Practicum: Real-Time Demonstration of the use of Adipose-Derived Stem Cells
- Current State of the Science: Technical Accomplishments and Hurdles Ahead
- Regulatory Trends Worldwide
- Research vs. Clinical Challenges in Stem Cell Translation
- The Route for Clinical Translation of Stem Cells: The Path to Commercialization
- Wound Healing and Cartilage Replacement: Research and Clinical Trends
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
SpeakersRobert Mays, Senior Director, Athersys Inc Dennis Clegg, Professor, University of California Santa Barbara Gary Oosta, Strategic Technology Assessment Analyst, Lee Buckler, Managing Director, Cell Therapy Group Allan Wu, Chief Scientific Officer, The Morrow Institute Akiko Futamura, President and Chief Executive Officer , InfiniteBio Mark Berman, President - American Academy of Cosmetic Surgery, California Stem Cell Treatment Center David Morrow, Founder, The Morrow Institute Fred Fox, Ethicist, BioMedical Research Institute -- BioMed IRB Mo Dao, Senior Scientist, Sanbio Mel Bircoll, Surgeon, California Academy of Cosmetic Surgery John Feller, Medical Director, Desert Medical Imaging Albert Lai, Chief Medical Officer, Centers of Rehabilitation and Pain Medicine Wade McKenna, President & Founder, Mckenna Orthopaedics, North Central Texas Orthpeadic Surgery and Sports Medicine
|